- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06697301
Et fase 2/3-studie for at evaluere sikkerheden og effektiviteten af EIK1001-006 i kombination med Pembrolizumab versus placebo og Pembrolizumab som førstelinjebehandling hos patienter med avanceret melanom
En multicenter, randomiseret, dobbeltblind, aktiv komparator-kontrolleret, adaptiv fase 2/3-undersøgelse til evaluering af sikkerheden og effektiviteten af EIK1001 og Pembrolizumab versus placebo og Pembrolizumab som førstelinjebehandling hos deltagere med avanceret melanom.
The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This is a Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK1001 and Pembrolizumab Versus Placebo and Pembrolizumab as First-Line Therapy in Participants with Advanced Melanoma. The study includes dose optimization and expansion parts.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 2
- Fase 3
Kontakter og lokationer
Studiekontakt
- Navn: Krishna Kaza, Director Clinical Study Management
- Telefonnummer: +1 (516) 675-6163
- E-mail: Kazak@eikontx.com
Studiesteder
-
-
New South Wales
-
Wollongong, New South Wales, Australien, 2500
- Rekruttering
- Cancer Care Wollongong
-
Kontakt:
- Sue Parker
- Telefonnummer: +61 242439708
- E-mail: Sparker@cancercarewollongong.com.au
-
Kontakt:
- Tabetha Gibson
- E-mail: TGibson@cancercarewollongong.com.au
-
Ledende efterforsker:
- Daniel Brungs
-
-
Queensland
-
Chermside, Queensland, Australien, 4032
- Rekruttering
- Icon Cancer Centre Chermside
-
Kontakt:
- Jesse Peet
- Telefonnummer: +07 3737 4539
- E-mail: Jesse.Peet@icon.team
-
Kontakt:
- Amy Goh
- Telefonnummer: +0438597944
- E-mail: amy.goh@icon.team
-
Ledende efterforsker:
- Chun Gan
-
-
South Australia
-
Bedford Park, South Australia, Australien, 5042
- Rekruttering
- Southern Adelaide Local Health Network Incorporated Flinders Medical Centre
-
Ledende efterforsker:
- Amitesh Roy
-
Kontakt:
- Alex Scott-Hoy
- Telefonnummer: 08 8204 4485
- E-mail: alex.scott-hoy@sa.gov.au
-
Kontakt:
- Alessia Belperio
- Telefonnummer: (08) 8204 5054
- E-mail: alessia.belperio@sa.gov.au
-
-
Victoria
-
Box Hill, Victoria, Australien, 3128
- Rekruttering
- Eastern Health
-
Kontakt:
- LaiWan Reid
- Telefonnummer: +61 474 871 676
- E-mail: laiwan.reid@monash.edu
-
Ledende efterforsker:
- Phillip Parente
-
Underforsker:
- Zhen R Siow
-
Frankston, Victoria, Australien, 3199
- Rekruttering
- Peninsula and South Eastern Haematology and Oncology Group
-
Ledende efterforsker:
- Vinod Ganju
-
Kontakt:
- Albert Goikhman
- Telefonnummer: +61 422510299
- E-mail: ag@paso.com.au
-
-
-
-
-
Sint-Niklaas, Belgien, 9100
- Rekruttering
- Vitaz Primary Location
-
Ledende efterforsker:
- Ines Deleu
-
Kontakt:
- Luna Van Hoyweghen
- Telefonnummer: +32 3760 7627
- E-mail: luna.vanhoyweghen@vitaz.be
-
-
Antwerpen
-
Edegem, Antwerpen, Belgien, 2650
- Rekruttering
- Universitair Ziekenhuis Antwerpen
-
Ledende efterforsker:
- Marika Rasschaert
-
Kontakt:
- Sandrine Harzé
- Telefonnummer: +3234368354
- E-mail: sandrine.harze@uza.be
-
Kontakt:
- Valerie Stragier
- Telefonnummer: +32 3 436 8091
- E-mail: valerie.stragier@uza.be
-
Underforsker:
- Timon Vandamme
-
-
Brussels Capital
-
Brussels, Brussels Capital, Belgien, 1200
- Rekruttering
- Cliniques Universitaires Saint-Luc
-
Kontakt:
- Louise Favaretto
- Telefonnummer: +32 2 764 35 13
- E-mail: louise.favaretto@saintluc.uclouvain.be
-
Kontakt:
- Beatriz Busine
- Telefonnummer: +32 2 764 13 31
- E-mail: guichetcommercial@saintluc.uclouvain.be
-
Ledende efterforsker:
- Jean-François Baurain Baurain
-
Underforsker:
- Frank Cornelis
-
-
Namur
-
Yvoir, Namur, Belgien, B-5530
- Rekruttering
- Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne
-
Kontakt:
- Mathilde Parmentier
- Telefonnummer: +32 0 81 42 38 57
- E-mail: mathilde.parmentier@chuuclnamur.uclouvain.be
-
Kontakt:
- Geraldine Mineur
- Telefonnummer: +32 81 42 38 55
- E-mail: geraldine.mineur@uclouvain.be
-
Ledende efterforsker:
- Laurence Faugeras
-
Underforsker:
- Quentin Gilliaux
-
-
Vlaams Brabant
-
Leuven, Vlaams Brabant, Belgien, 3000
- Rekruttering
- Universitair Ziekenhuis Leuven - Campus Gasthuisberg
-
Kontakt:
- Loulou Dourée
- Telefonnummer: +32 16 34 39 44
- E-mail: loulou.douree@uzleuven.be
-
Kontakt:
- Marjolein Dom
- Telefonnummer: +32 16 34 59 91
- E-mail: marjolein.dom@uzleuven.be
-
Ledende efterforsker:
- Oliver Bechter
-
Underforsker:
- Patrick Schöffski
-
-
West-Vlaanderen
-
Kortrijk, West-Vlaanderen, Belgien, 8500
- Rekruttering
- Algemeen Ziekenhuis Groeninge - Campus Kennedylaan
-
Kontakt:
- Inge Meyer
- Telefonnummer: +32 56 63 39 40
- E-mail: inge.meyer@azgroeninge.be
-
Kontakt:
- Angel Remmerie
- Telefonnummer: +32 56 63 39 75
- E-mail: cta.oncologie@azgroeninge.be
-
Ledende efterforsker:
- Veronique Buyse
-
Underforsker:
- Tine Loyson
-
-
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- Rekruttering
- Sunnybrook Research Ins<tute
-
Ledende efterforsker:
- Rossanna Pezo
-
Kontakt:
- Stephanie Lewaniak
- Telefonnummer: 689957 +1 416-480-5000
- E-mail: stephanie.lewaniak@sunnybrook.ca
-
Kontakt:
- Carolyn Lim
- Telefonnummer: 67219 +1 416-480-5000
- E-mail: carolyn.lim@sunnybrook.ca
-
Underforsker:
- Teresa Petrella
-
-
-
-
Central Jutland
-
Aarhus, Central Jutland, Danmark, 8200
- Suspenderet
- Aarhus Universitetshospital
-
-
Nord Jutland
-
Aalborg, Nord Jutland, Danmark, 9000
- Suspenderet
- Aalborg University Hospital
-
-
-
-
Belfast
-
Belfast, Belfast, Det Forenede Kongerige, BT9 7AB
- Rekruttering
- Belfast City Hospital, Belfast Health and Social Care Trust
-
Kontakt:
- Eimear Nicholl
- Telefonnummer: 47412 +4428 9504 7412
- E-mail: Eimear.nicholl@belfasttrust.hsc
-
Ledende efterforsker:
- Bode Oladipo
-
-
England
-
London, England, Det Forenede Kongerige, SE1 9RT
- Rekruttering
- Guy's and St Thomas' NHS Foundation Trust
-
Kontakt:
- Rumana Parvin
- Telefonnummer: 57422 020 7188 7188
- E-mail: rumana.parvin@gstt.nhs.uk
-
Kontakt:
- Taiwo Oguntoyinbo
- Telefonnummer: 82019/57422 020 7188 2019
- E-mail: taiwo.guntoyinbo@gstt.nhs.uk
-
Ledende efterforsker:
- Alvin Lee
-
London, England, Det Forenede Kongerige, W1G6AD
- Rekruttering
- Sarah Cannon Research Institute London
-
Ledende efterforsker:
- Anja Williams
-
Kontakt:
- Sebastian Agredo
- Telefonnummer: +44 203 219 5211
- E-mail: Sebastian.Agredo@hcahealthcare.co.uk
-
Underforsker:
- Elisa Fontana
-
-
Hampshire
-
Southampton, Hampshire, Det Forenede Kongerige, SO32 2DA
- Rekruttering
- University Hospital Southampton
-
Kontakt:
- Connie Temple-Brown
- Telefonnummer: +44 2380777222
- E-mail: constance.temple-brown@uhs.nhs.uk
-
Ledende efterforsker:
- Matthew Wheater
-
-
-
-
Oulu
-
Oulu, Oulu, Finland, 90230
- Rekruttering
- Oulu University Hospital
-
Kontakt:
- Raija Mikkonen
- Telefonnummer: +358405057872
- E-mail: raija.mikkonen@pohde.fi
-
Ledende efterforsker:
- Sanna Livanainen
-
-
Pirkanmaa
-
Tampere, Pirkanmaa, Finland, 33521
- Rekruttering
- Tampere University Hospital
-
Kontakt:
- Marjo Koivisto
- Telefonnummer: +358444728004
- E-mail: marjo.koivisto@pirha.fi
-
Ledende efterforsker:
- Tanja Skyttä
-
-
Uusimaa
-
Helsinki, Uusimaa, Finland, 00029
- Rekruttering
- Helsinki University Hospital
-
Kontakt:
- Jacoba Peterson-Hirvonen
- Telefonnummer: +358-50-372 9043
- E-mail: jacoba.peterson-hirvonen@hus.fi
-
Ledende efterforsker:
- Micaela Hernberg
-
-
-
-
Arizona
-
Chandler, Arizona, Forenede Stater, 85224
- Rekruttering
- Ironwood Cancer & Research Centers
-
Kontakt:
- Tiffany Wales
- Telefonnummer: 27104 480-256-1372
- E-mail: TIffany.Walas@ironwoodcrc.com
-
Ledende efterforsker:
- Amikar Sehdev, MD
-
-
Arkansas
-
Hot Springs, Arkansas, Forenede Stater, 71913
- Rekruttering
- Genesis Cancer and Blood Institute
-
Ledende efterforsker:
- Robert Muldoon
-
Kontakt:
- Laura Sellers
- Telefonnummer: 63839 5016247700
- E-mail: Laura.Sellers@aoncology.com
-
-
California
-
Los Angeles, California, Forenede Stater, 90015
- Rekruttering
- Helios Clinical Research
-
Ledende efterforsker:
- Pamela Miel
-
Kontakt:
- Sabrina Mora
- Telefonnummer: 562-735-3226
- E-mail: Sabrinamora@theoncologyinstitute.com
-
Kontakt:
- Leslie Posadas
- E-mail: leslieposadas@theoncologyinstitute.com
-
Santa Rosa, California, Forenede Stater, 95403
- Rekruttering
- Providence Medical Foundation
-
Ledende efterforsker:
- David Park
-
Underforsker:
- Natalie Valle
-
Kontakt:
- Linda Gozar
- Telefonnummer: 4332 +1 714-992-3000
- E-mail: Linda.Gozar@stjoe.org
-
-
Colorado
-
Colorado Springs, Colorado, Forenede Stater, 80909
- Rekruttering
- UCHealth Memorial Hospital Central
-
Kontakt:
- Ashley Miller
- Telefonnummer: 719-365-5062
- E-mail: ashley.miller5@uchealth.org
-
Ledende efterforsker:
- Stacey ParkerBrueggemann, MD
-
-
Delaware
-
Newark, Delaware, Forenede Stater, 19713
- Rekruttering
- Christiana Care
-
Ledende efterforsker:
- Jamal Misleh
-
Kontakt:
- Jennifer Knotts
- Telefonnummer: 302- 623-4889
- E-mail: JKnotts@christianacare.org
-
Kontakt:
- Julie Falango
- E-mail: Julie.falango@christianacare.org
-
Underforsker:
- Darryl Chang
-
-
Florida
-
Hialeah, Florida, Forenede Stater, 33013
- Rekruttering
- Bioresearch Partner
-
Kontakt:
- Tahimi Campa
- Telefonnummer: 833-489-4968
- E-mail: tdelacampa@bioresearchpartner.com
-
Kontakt:
- Mabel Cruz
- Telefonnummer: 833-489-4968
- E-mail: mcruz@bioresearchpartner.com
-
Ledende efterforsker:
- Luis Rangel
-
Tamarac, Florida, Forenede Stater, 33321
- Rekruttering
- Florida Clinical Trials Group - Tamarac
-
Ledende efterforsker:
- Chintan Gandhi
-
Kontakt:
- Maria Abreu
- Telefonnummer: (772) 297-3057
- E-mail: abreum@floridactg.com
-
Kontakt:
- Mairan Rivera
- Telefonnummer: 772-297-3057
- E-mail: riveram@floridactg.com
-
Underforsker:
- Lauren Brito
-
-
Maryland
-
Bethesda, Maryland, Forenede Stater, 20817
- Rekruttering
- The Center for Cancer and Blood Disorders
-
Ledende efterforsker:
- Victor Priego
-
Kontakt:
- Taylor Stutzman
- Telefonnummer: 301-571-2016
- E-mail: taylor.stutzman@aoncology.com
-
-
Missouri
-
Kansas City, Missouri, Forenede Stater, 64132
- Rekruttering
- MidAmerica Cancer Care
-
Ledende efterforsker:
- Jaswinder Singh
-
Kontakt:
- Logan Marney
- Telefonnummer: 833-886-1725
- E-mail: Logan.Marney@aoncology.com
-
St Louis, Missouri, Forenede Stater, 63108
- Rekruttering
- Washington University School of Medicine in St. Louis
-
Ledende efterforsker:
- George Ansstas
-
Kontakt:
- Kelsey Etter
- Telefonnummer: 314-273-0656
- E-mail: etter@wustl.edu
-
Underforsker:
- Nicole Chrisman
-
-
Ohio
-
Canton, Ohio, Forenede Stater, 44718
- Rekruttering
- Gabrail Cancer Center Research LLC
-
Ledende efterforsker:
- Nashat Gabrail
-
Kontakt:
- Carrie Smith
- Telefonnummer: 330-417-8231
- E-mail: csmith@gabrailcancercenter.com
-
Underforsker:
- Carmen Baldwin
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forenede Stater, 15232
- Rekruttering
- University of Pittsburgh Medical Center(UPMC)-Hillman Cancer Center
-
Ledende efterforsker:
- Diwakar Davar, MD
-
Kontakt:
- Danielle Bednarz
- Telefonnummer: 412 623-1191
- E-mail: bednarzdl@upmc.edu
-
-
Texas
-
Sugar Land, Texas, Forenede Stater, 77479
- Rekruttering
- Patientcare Clinical Research
-
Ledende efterforsker:
- Amir Rasheed
-
Kontakt:
- Muhammad Muzammil
- Telefonnummer: 1 (732) 358-3048
- E-mail: muzammil@patientcareclinicalresearch.com
-
Underforsker:
- Jianwen Dong
-
-
-
-
-
Bordeaux, Frankrig, 33075
- Rekruttering
- Hospital Saint Andre
-
Kontakt:
- Gaelle Domingo
- Telefonnummer: +33557820655
- E-mail: gaelle.domingo@chu-bordeaux.fr
-
Ledende efterforsker:
- Caroline Dutriaux
-
-
Auvergne-Rhône-Alpes
-
Pierre-Bénite, Auvergne-Rhône-Alpes, Frankrig, 69495
- Rekruttering
- Centre Hospitalier Lyon-Sud
-
Ledende efterforsker:
- Stéphane Dalle
-
Kontakt:
- Caroline Marchi
- Telefonnummer: +33 04 78 86 33 35
- E-mail: caroline.marchi@chu-lyon.fr
-
-
Boulogne
-
Boulogne, Boulogne, Frankrig, 92104
- Rekruttering
- A Paré
-
Ledende efterforsker:
- Philippe Saiag
-
Kontakt:
- Veronique Clerisse
- Telefonnummer: +33618458154
- E-mail: veronique.clerisse@aphp.fr
-
Kontakt:
- Marine Masson
- Telefonnummer: +33 1 49 09 52 75
- E-mail: marinesuzanne.masson@aphp.fr
-
-
Isère
-
La Tronche, Isère, Frankrig, 38700
- Rekruttering
- Centre Hospitalier Universitaire Grenoble Alpes
-
Ledende efterforsker:
- Julie Charles
-
Kontakt:
- Stéphane Mouret
- Telefonnummer: +33476767081
- E-mail: smouret1@chu-grenoble.fr
-
-
Lille Cedex
-
Lille, Lille Cedex, Frankrig, 59037
- Rekruttering
- CHU Lille
-
Kontakt:
- Léa Malvoisin
- Telefonnummer: +33320446415
- E-mail: lea.malvoisin@chu-lille.fr
-
Kontakt:
- Sara Aliouane
- Telefonnummer: +33320443597
- E-mail: sara.aliouane@chu-lille.fr
-
Ledende efterforsker:
- Laurent Mortier
-
-
Marseille
-
Marseille, Marseille, Frankrig, 13385
- Rekruttering
- Hôpital La Timone
-
Kontakt:
- Kahina DJENAD-ICHALLAL
- Telefonnummer: +33 0491 38 88 03
- E-mail: Kahina.DJENAD@ap-hm.fr
-
Ledende efterforsker:
- Caroline Gaudy
-
-
PACA
-
Nice, PACA, Frankrig, 06200
- Rekruttering
- Centre Hospitalier Universitaire (CHU) Nice
-
Kontakt:
- Emmanuelle Pradelli
- Telefonnummer: +33492036667
- E-mail: pradelli.e@chu-nice.fr
-
Ledende efterforsker:
- Henri Montaudie
-
-
Paris
-
Paris, Paris, Frankrig, 75018
- Rekruttering
- Hôpital Bichat AP-HP Université Paris Cité
-
Kontakt:
- Sabrina Djerroud
- Telefonnummer: +33 1 40 25 64 63
- E-mail: sabrina.djerroud@aphp.fr
-
Ledende efterforsker:
- Florence Brunet-Possenti
-
-
Pays de la Loire Region
-
Saint-Herblain, Pays de la Loire Region, Frankrig, 44800
- Rekruttering
- ICO Saint Herblain
-
Kontakt:
- Caoline Perrault
- Telefonnummer: +33 2 40 67 99 1
- E-mail: caroline.perrault@ico.unicancer.fr
-
Kontakt:
- Elodie Planchais
- Telefonnummer: +33 2 40 67 99 00
- E-mail: elodie.planchais@ico.unicancer.fr
-
Ledende efterforsker:
- Mélanie Saint-Jean
-
-
Rouen
-
Rouen, Rouen, Frankrig, 76031
- Rekruttering
- CHU Rouen
-
Kontakt:
- Elodie Geant
- Telefonnummer: 6 66 99 (33) 02 32 88 66 99
- E-mail: elodie.geant@chu-rouen.fr
-
Ledende efterforsker:
- Anne Benedicte Duval Modeste
-
-
-
-
Be'er Sheva
-
Beersheba, Be'er Sheva, Israel, 8410101
- Rekruttering
- Soroka medical center
-
Kontakt:
- Margarita Boltian
- Telefonnummer: 972 8-6403375
- E-mail: margaritabol@clalit.org.il
-
Ledende efterforsker:
- Alexander Yakobson
-
-
Petach Tikva
-
Petah Tikva, Petach Tikva, Israel, 4941492
- Rekruttering
- Rabin Medical Center
-
Kontakt:
- Noa Konvalina
- Telefonnummer: +97239378077
- E-mail: noakon@clalit.org.il
-
Ledende efterforsker:
- Nethanel Asher
-
-
Ramat Gan
-
Ramat Gan, Ramat Gan, Israel, 5262100
- Rekruttering
- Ella Lemelbaum Institute for Immuno-Oncology and Melanoma
-
Kontakt:
- Osnat Mazuz
- Telefonnummer: +972 35307916
- E-mail: osnat.mazuz@sheba.health.gov.il
-
Ledende efterforsker:
- Ronnie Shapira-Frommer
-
Underforsker:
- Raz Mutai
-
-
Tel Aviv
-
Tel Aviv, Tel Aviv, Israel, 6423906
- Rekruttering
- Tel Aviv Medical Center
-
Kontakt:
- Hagit Damchiner-Pearl
- Telefonnummer: 972-52-7360519
- E-mail: hagitdp@tlvmc.gov.il
-
Ledende efterforsker:
- Mor Miodovnik
-
-
-
-
Foggia
-
San Giovanni Rotondo, Foggia, Italien, 71013
- Rekruttering
- Ospedale Casa Sollievo Della Sofferenza
-
Kontakt:
- Carmela D'Arienzo
- Telefonnummer: +39 0882410716
- E-mail: c.darienzo@operapadrepio.it
-
Kontakt:
- Cinzia Chiarazzo
- Telefonnummer: +39 0882410716
- E-mail: cinzia.chiarazzo@gmail.com
-
Ledende efterforsker:
- Gabriele Di Maggio
-
Underforsker:
- Antonella Centonza
-
-
Italy
-
Alessandria, Italy, Italien, 15121
- Rekruttering
- Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo
-
Ledende efterforsker:
- Federica Grosso
-
Kontakt:
- Alessia Garau
- Telefonnummer: +39 0131 206852
- E-mail: alessia.garau@aou.al.it
-
Kontakt:
- Lorenzo Lobina
- Telefonnummer: +39 0131 206852
- E-mail: lorenzo.lobina@aou.al.it
-
Underforsker:
- Delfanti Sara
-
Messina, Italy, Italien, 98039
- Rekruttering
- Ospedale San Vincenzo Taormina
-
Kontakt:
- Simone Cardone
- Telefonnummer: +39 3456108735
- E-mail: simonacardone@hotmail.it
-
Kontakt:
- Carmela Pania
- Telefonnummer: +39 3496619293
- E-mail: carmela.pania@asp.messina.it
-
Ledende efterforsker:
- Francesco Ferraù
-
Underforsker:
- Elena Torrisi
-
Milan, Italy, Italien, 20133
- Rekruttering
- Fondazione IRCSS - Istituto Nazionale dei Tumori
-
Kontakt:
- Ilaria Bisogno
- Telefonnummer: +390223902894
- E-mail: ilaria.bisogno@istitutotumori.mi.it
-
Kontakt:
- Maria Montesanto
- Telefonnummer: +39 0223903839
- E-mail: maria.montesanto@istitutotumori.mi.it
-
Ledende efterforsker:
- Michele Del Veccio
-
Underforsker:
- Andrea Spagnoletti
-
Modena, Italy, Italien, 41125
- Rekruttering
- AOU Policlinico di Modena
-
Kontakt:
- Cristiana Rossetti
- Telefonnummer: +39 0594222061
- E-mail: rossetti.cristiana@aou.mo.it
-
Kontakt:
- Michela Palmieri
- Telefonnummer: +39 0594222062
- E-mail: mpalmier@unimore.it
-
Ledende efterforsker:
- Roberta Depenni
-
Underforsker:
- Stefano Greco
-
Padova, Italy, Italien, 35128
- Rekruttering
- Istituto Oncologico Veneto IRCCS
-
Kontakt:
- Davide Campagnolo
- Telefonnummer: +39 0498215981
- E-mail: davide.campagnolo@iov.veneto.it
-
Kontakt:
- Giovanna Chiara Surace
- Telefonnummer: +39 0498215982
- E-mail: giovannachiara.surace@iov.veneto.it
-
Ledende efterforsker:
- Jacopo Pigozzo
-
Underforsker:
- Luisa Piccin
-
Trento, Italy, Italien, 38123
- Rekruttering
- Azienda Provinciale per I Servizi Sanitari
-
Kontakt:
- Renza Triolo
- Telefonnummer: +39 0461903178
- E-mail: renza.triolo@asuit.tn.it
-
Kontakt:
- Roberta Biondi
- Telefonnummer: +39 0461904747
- E-mail: roberta.biondi@asuit.tn.it
-
Ledende efterforsker:
- Sonia Brugnara
-
Underforsker:
- Federico Sganzerla
-
-
Liguria
-
Genoa, Liguria, Italien, 16132
- Rekruttering
- IRCCS Ospedale Policlinico San Marino
-
Kontakt:
- Cristiana Fava
- Telefonnummer: +39 010 5558916
- E-mail: cristiana.fava@aomliguria.it
-
Kontakt:
- Alessia Graziana Bosio
- Telefonnummer: +39 010 5558911
- E-mail: alessiagraziana.bosio@aomliguria.it
-
Ledende efterforsker:
- Francesco Spagnolo
-
Underforsker:
- Andrea Boutros
-
-
Milano
-
Milan, Milano, Italien, 20132
- Rekruttering
- IRCCS Ospedale San Raffaele
-
Kontakt:
- Nicola Fogale
- Telefonnummer: +39 02 2643 9024
- E-mail: fogale.nicola@hsr.it
-
Ledende efterforsker:
- Vincenzo Russo
-
-
Province of Bergamo
-
Bergamo, Province of Bergamo, Italien, 24125
- Rekruttering
- Humanitas Gavazzeni Bergamo
-
Kontakt:
- Paola Maggioni
- Telefonnummer: +39 0354204760
- E-mail: paola.maggioni@gavazzeni.it
-
Ledende efterforsker:
- Laura Pala
-
-
The Marches
-
Ancona, The Marches, Italien, 60126
- Rekruttering
- Clinica Oncologia Delle Marche
-
Ledende efterforsker:
- Rossana Berardi
-
Kontakt:
- Alessandra Lucarelli
- Telefonnummer: +39 071 5965093
- E-mail: alessandra.lucarelli@ospedaliriuniti.marche.it
-
-
Tuscany
-
Siena, Tuscany, Italien, 53100
- Rekruttering
- UOC Immunoterapia Oncologica
-
Kontakt:
- Elisa Ibba
- Telefonnummer: +39 577586056
- E-mail: elisa.ibba@ao-siena.toscana.it
-
Ledende efterforsker:
- Anna Maria Di Giacomo
-
-
-
-
Christchurch
-
Christchurch, Christchurch, New Zealand, 8011
- Rekruttering
- Christchurch Public Hospital
-
Kontakt:
- Katharine Moore
- Telefonnummer: +64 2740 66867
- E-mail: Katharine.Moore@cdhb.health.nz
-
Ledende efterforsker:
- David Gibbs
-
-
New Zealand
-
Auckland, New Zealand, New Zealand, 1023
- Rekruttering
- Auckland City Hospital
-
Kontakt:
- Jessica Lalanne
- Telefonnummer: 21837 +64 9 3074949
- E-mail: jlalanne@adhb.govt.nz
-
Kontakt:
- Ruta Padalkar
- Telefonnummer: +64 9 3074949
- E-mail: RutaP@adhb.govt.nz
-
Ledende efterforsker:
- Gareth Rivalland, MD
-
-
-
-
Bodø
-
Bodø, Bodø, Norge, N-8005
- Rekruttering
- Nordland Hospital Trust
-
Kontakt:
- Petter Øien
- Telefonnummer: +47 75599133
- E-mail: petter.oien@nlsh.no
-
Ledende efterforsker:
- Bard Mannsaker
-
-
Oslo
-
Oslo, Oslo, Norge, 0310
- Rekruttering
- Oslo University Hospital - The Norwegian Radium Hospital
-
Kontakt:
- Kirsten Hagene
- Telefonnummer: +47 99293273
- E-mail: kihage@ous-hf.no
-
Ledende efterforsker:
- Marta Nyakas
-
-
Oslofjord
-
Drammen, Oslofjord, Norge, 3004
- Rekruttering
- Drammen Hospital
-
Kontakt:
- Siri Bråthen
- Telefonnummer: +47 32862464
- E-mail: siri.brathen@vestreviken.no
-
Underforsker:
- Alina Carmen Porojnicu
-
-
-
-
Gdańsk
-
Gdansk, Gdańsk, Polen, 80-952
- Rekruttering
- Uniwersyteckie Centrum Kliniczne
-
Kontakt:
- Elżbieta Kurzawa
- Telefonnummer: +48517331593
- E-mail: ekurzawa@uck.gda.pl
-
Ledende efterforsker:
- Kamil Drucis
-
-
Konin
-
Konin, Konin, Polen, 62-500
- Rekruttering
- Prezychodnia Lekarska KOMED Roman Karaszewski
-
Ledende efterforsker:
- Bogusława Karaszewska
-
Kontakt:
- Dorota Pospieszynska
- Telefonnummer: +48632406136
- E-mail: d.pospieszynska45@gmail.com
-
-
Siedlce
-
Siedlce, Siedlce, Polen, 08-110
- Rekruttering
- Mazowiecki Szpital Wojewódzki, Siedlckie Centrum Onkologii
-
Ledende efterforsker:
- Lubomir Bodnar
-
Kontakt:
- Tomasz Milewski
- Telefonnummer: +48600173523
- E-mail: tmilewski@szpital.siedlce.pl
-
-
Silesian Voivodeship
-
Gliwice, Silesian Voivodeship, Polen, 44-102
- Rekruttering
- Maria Sklodowska-Curie Na;onal Research Ins;tute of Oncology, Gliwice Branch
-
Ledende efterforsker:
- Wieslaw Bal
-
Kontakt:
- Dorota Trzcińska
- Telefonnummer: +48 32-278-8237
- E-mail: Dorota.trzcinska@gliwice.nio.gov.pl
-
Kontakt:
- Anna Hebda
- Telefonnummer: +48 32-278-8237
- E-mail: anna.hebda@gliwice.nio.gov.pl
-
Underforsker:
- Anna Kotas
-
-
Warsaw
-
Warsaw, Warsaw, Polen, 02-781
- Rekruttering
- Maria Sklodowska-Curie National Cancer Research Institute
-
Kontakt:
- Anna Gluszcz
- Telefonnummer: +48 22 546 26 03
- E-mail: anna.gluszcz@nio.gov.pl
-
Ledende efterforsker:
- Anna Czarnecka
-
-
-
-
Lisbon District
-
Lisbon, Lisbon District, Portugal, 1500-650
- Rekruttering
- Hospital da Luz Lisboa
-
Kontakt:
- Catarina Aleixo
- Telefonnummer: 44659 +351.217.104.544
- E-mail: caleixo@hospitaldaluz.pt
-
Kontakt:
- Filipa Nunes
- Telefonnummer: 44660 +351 217 104 400
- E-mail: filipa.nunes@luzsaude.pt
-
Ledende efterforsker:
- Gonçalo Fernandes
-
Lisbon, Lisbon District, Portugal, 1099-023
- Rekruttering
- IPO Lisboa
-
Kontakt:
- Bruna Pavia
- Telefonnummer: +35 933464102
- E-mail: bpavia@ipolisboa.min-saude.pt
-
Ledende efterforsker:
- Patricia Pereira
-
-
-
-
Canton of Zurich
-
Zurich, Canton of Zurich, Schweiz, 8091
- Rekruttering
- Universitätsspital Zürich
-
Ledende efterforsker:
- Egle Ramelyte
-
Kontakt:
- Lucien Morel
- Telefonnummer: +41 44 255 18 59
- E-mail: lucien.morel@usz.ch
-
Kontakt:
- Julia Püschel
- Telefonnummer: +41 44 255 9485
- E-mail: julia.pueschel@usz.ch
-
Underforsker:
- Michele Welti
-
-
Chur
-
Chur, Chur, Schweiz, 7000
- Rekruttering
- Kantonsspital Graubünden
-
Kontakt:
- Gabriela Manetsch
- Telefonnummer: +41812566860
- E-mail: gabriela.manetsch@ksgr.ch
-
Ledende efterforsker:
- Roger von Moos
-
-
-
-
Belgrade
-
Belgrade, Belgrade, Serbien, 11000
- Rekruttering
- Military Medical Academy- Department of Oncology
-
Kontakt:
- Vesna Nesic
- Telefonnummer: +381641452888
- E-mail: vesnanesic8@gmail.com
-
Ledende efterforsker:
- Lidija Kandolf
-
-
-
-
-
Cadiz, Spanien, 11407
- Rekruttering
- University Hospital of Jerez
-
Kontakt:
- Mari Carmen Leon
- Telefonnummer: +34 956 03 22 44
- E-mail: carmen.oncojerez@gmail.com
-
Ledende efterforsker:
- Regina Garcia Galindo
-
Underforsker:
- Gloria Aguilera
-
-
A Coruña
-
Santiago de Compostela, A Coruña, Spanien, 15706
- Rekruttering
- Hospital Clínico de Santiago de Compostela
-
Kontakt:
- Veronica Rivas
- Telefonnummer: 256332 +34 981956332
- E-mail: veronica.rivas.limeres@gmail.com
-
Ledende efterforsker:
- Teresa Curiel
-
Underforsker:
- Alexandra Mosquera
-
-
Badalona
-
Badalona, Badalona, Spanien, 08916
- Rekruttering
- H. Germans Trias I Pujol (ICO-Badalona)
-
Kontakt:
- Laura Millares Costas
- Telefonnummer: +34 677254583
- E-mail: lmillares@iconcologia.net
-
Ledende efterforsker:
- José Manzano
-
-
Barcelona
-
Barcelona, Barcelona, Spanien, 08028
- Rekruttering
- Hospital Universitari Dexeus
-
Kontakt:
- Carlos Esparre
- Telefonnummer: +34 93 54 60 143
- E-mail: cesparre@oncorosell.com
-
Kontakt:
- Marta Juan
- Telefonnummer: +34 93 54 60 143
- E-mail: mjuan@oncorosell.com
-
Ledende efterforsker:
- Maria G Cao
-
Underforsker:
- Josep S Ortega
-
Barcelona, Barcelona, Spanien, 08035
- Rekruttering
- Vall d' Hebron Institute of Oncology
-
Kontakt:
- Alba Barrio
- Telefonnummer: 8827 (+34) 93 254 34 50
- E-mail: bbruno@vhio.net
-
Kontakt:
- Núria Llansana
- Telefonnummer: 5063 (+34) 93 254 3450
- E-mail: nfarras@vhio.net
-
Ledende efterforsker:
- Eva M Couselo
-
-
Cantabria
-
Santander, Cantabria, Spanien, 39008
- Rekruttering
- Hospital Universitario Marques de Valdecilla
-
Ledende efterforsker:
- Marta García
-
Kontakt:
- Laura Pérez
- Telefonnummer: +34 942 20 33 51
- E-mail: laura.revuelta@idival.org
-
Underforsker:
- Belen Caramelo
-
-
Cáceres
-
Cáceres, Cáceres, Spanien, 10003
- Rekruttering
- San Pedro de Alcántara Hospital
-
Kontakt:
- Julia Cruces González
- Telefonnummer: +34 927256406
- E-mail: julia.crucesgonzalez@externos.salud-juntaex.es
-
Ledende efterforsker:
- Pablo Ayala
-
-
Galicia
-
Lugo, Galicia, Spanien, 27003
- Rekruttering
- Hospital Universitario Lucus Augusti
-
Kontakt:
- Raquel Romero
- Telefonnummer: +34 982 296459
- E-mail: raquel.romero.van.der.schoot@sergas.es
-
Ledende efterforsker:
- Begona Campos Balea
-
-
Girona
-
Girona, Girona, Spanien, 17007
- Rekruttering
- Institut Català d'Oncologia Girona (ICO Girona)
-
Kontakt:
- Begoña M Castillo
- Telefonnummer: +34 972 22 58 28
- E-mail: bmartin@iconcologia.net
-
Kontakt:
- Bruna Castilhos
- E-mail: nmartin@iconcologia.net
-
Underforsker:
- Anna Carbó
-
Ledende efterforsker:
- Elisabet Bujons
-
-
Madrid
-
Madrid, Madrid, Spanien, 28007
- Rekruttering
- Hospital General Universitario Gregorio Marañón
-
Kontakt:
- Isabel Cañete
- Telefonnummer: 915868161
- E-mail: icg.hgugm@gmail.com
-
Ledende efterforsker:
- IVAN MARQUEZ
-
Madrid, Madrid, Spanien, 28002
- Rekruttering
- GenesisCare Madrid - Hospital San Francisco de Asís
-
Kontakt:
- Araceli Rodriguez
- Telefonnummer: +34 916219256
- E-mail: arodriguez.oncologytrials@gmail.com
-
Ledende efterforsker:
- José Angel Garcia Cuesta
-
Madrid, Madrid, Spanien, 28050
- Rekruttering
- HM CIOCC
-
Kontakt:
- Paloma Vargas Durán
- Telefonnummer: +4814 +34 91 756 78 00
- E-mail: pvargas@hmhospitales.com
-
Ledende efterforsker:
- Juan Rodriguez Moreno
-
Usera, Madrid, Spanien, 28031
- Rekruttering
- Hospital 12 de Octubre
-
Kontakt:
- Maria Jesus Perez Lorenzo
- Telefonnummer: +34913908547
- E-mail: startup.oncology.imas12@h12o.es
-
Ledende efterforsker:
- Guillermo De Velasco
-
-
Malaga
-
Málaga, Malaga, Spanien, 29011
- Rekruttering
- Hospital Regional Universitario
-
Kontakt:
- Irene Rojas García
- Telefonnummer: +34 608093004
- E-mail: ensayosch@yahoo.es
-
Ledende efterforsker:
- Miguel Angel Berciano
-
-
Murcia
-
Murcia, Murcia, Spanien, 30120
- Rekruttering
- Hospital Clinico Universitario Virgen de la Arrixaca
-
Kontakt:
- Paula Ruiz
- Telefonnummer: +34 968 36 91 51
- E-mail: dm.oncoarrixaca2@gmail.com
-
Ledende efterforsker:
- Pablo Fuentes
-
Underforsker:
- Miguel Angel Moya
-
-
Málaga
-
Málaga, Málaga, Spanien, 29010
- Rekruttering
- Hospital Universitario Virgen de la Victoria
-
Kontakt:
- Desireeh Fernandez
- Telefonnummer: +34 951032508
- E-mail: desireeh.fernandez@ibima.eu
-
Ledende efterforsker:
- Manuel Zalabardo
-
-
Spain
-
Barcelona, Spain, Spanien, 8036
- Rekruttering
- Hospital Clinic Barcelona
-
Kontakt:
- Nadina Fradera
- Telefonnummer: 383541 (+34) 687727943
- E-mail: fradera@recerca.clinic.cat
-
Kontakt:
- Julio Vidal
- Telefonnummer: 381716 +39 663 467 747
- E-mail: juvidal@recerca.clinic.cat
-
Ledende efterforsker:
- Ana Arance
-
Underforsker:
- Maribel Marmol
-
-
Valencia
-
Valencia, Valencia, Spanien, 46009
- Rekruttering
- IVO - Fundacion Instituto Valenciano de Oncologia
-
Ledende efterforsker:
- Maria Jose Juan Fita
-
Kontakt:
- Raquel Bayona
- Telefonnummer: 671429340
- E-mail: datamanager33@fincivo.org
-
Kontakt:
- Belen Vazquez
- Telefonnummer: 663224875
- E-mail: coordinacion@fincivo.org
-
Underforsker:
- Eduardo Nagore
-
Valencia, Valencia, Spanien, 46010
- Rekruttering
- INCLIVA Instituto de Investigación Sanitaria
-
Underforsker:
- Valentina Gambardella
-
Kontakt:
- Paqui Fernandez
- Telefonnummer: 436696 +34) 96 197 35 00
- E-mail: ffernandez@incliva.es
-
Kontakt:
- Paloma Campos
- Telefonnummer: +34 682 43 47 08
- E-mail: pcampos@incliva.es
-
Ledende efterforsker:
- Ines G Barrallo
-
-
-
-
Gävleborg County
-
Gävle, Gävleborg County, Sverige, 801 88
- Rekruttering
- Gävle Sjukhus
-
Kontakt:
- Ulrika Åsenlund
- Telefonnummer: +46 722077689
- E-mail: ulrika.asenlund@regiongavleborg.se
-
Ledende efterforsker:
- Ilke Cikman
-
Underforsker:
- Olga Del Val Munoz
-
-
Södermanland County
-
Stockholm, Södermanland County, Sverige, 17176
- Rekruttering
- Karolinska University Hospital
-
Kontakt:
- Johanna Lofberg Betts
- Telefonnummer: +46 8 12373388
- E-mail: johanna.lofberg-betts@regionstockholm.se
-
Ledende efterforsker:
- Hannah Eriksson
-
-
-
-
Eastern Cape
-
Port Elizabeth, Eastern Cape, Sydafrika, 6045
- Rekruttering
- Cancercare Port Elizabeth - Langenhoven Drive Oncology Centre
-
Kontakt:
- Anna Szőke
- Telefonnummer: +36 209529 303
- E-mail: aszoke@ledgerrun.com
-
Ledende efterforsker:
- John Crockett
-
Underforsker:
- Sakina Bawa
-
-
Gauteng
-
Pretoria, Gauteng, Sydafrika, 0002
- Rekruttering
- University of Pretoria, Steve Biko Academic Hospital
-
Ledende efterforsker:
- Richard Khanyile
-
Kontakt:
- Venolia Mohlabine
- Telefonnummer: +27 12 354 2022
- E-mail: Venolia.Mohlabine@up.ac.za
-
Saxonwold, Gauteng, Sydafrika, 2196
- Rekruttering
- The Medical Oncology Centre of Rosebank
-
Kontakt:
- Teresa Smit
- Telefonnummer: 0027828805944
- E-mail: data@rapoport.co.za
-
Ledende efterforsker:
- Bernardo Rapoport
-
-
KwaZulu-Natal
-
Richards Bay, KwaZulu-Natal, Sydafrika, 3900
- Rekruttering
- Abraham Oncology
-
Ledende efterforsker:
- Smitha Abraham
-
Kontakt:
- Debbie Jacobs
- Telefonnummer: +27 347800247
- E-mail: debbie@drabraham.co.za
-
-
Pretoria
-
Pretoria, Pretoria, Sydafrika, 0084
- Rekruttering
- Curo Oncology
-
Kontakt:
- Lenore Dirker
- Telefonnummer: +27 12 335 6771
- E-mail: research@curo-oncology.co.za
-
Ledende efterforsker:
- Rouchelle Marais-Nieman
-
-
Western Cape
-
Cape Town, Western Cape, Sydafrika, 7570
- Rekruttering
- Cape Town Oncology Trials
-
Ledende efterforsker:
- Corlia Coetzee
-
Kontakt:
- Theo Niemand
- Telefonnummer: +27 (0)71 129 1765
- E-mail: theo.niemand@ctot.co.za
-
Kontakt:
- Pieter Laubscher
- Telefonnummer: +27 (0)82 748 3608
- E-mail: pieter.laubscher@ctot.co.za
-
Underforsker:
- Johann Riedemann
-
George, Western Cape, Sydafrika, 6529
- Rekruttering
- TASK Eden
-
Kontakt:
- Pieter Lennox
- Telefonnummer: +27 (0) 82 853 4991
- E-mail: pieter@task.org.za
-
Kontakt:
- Susanna Loock
- Telefonnummer: +27 72 423 4763
- E-mail: sumaria.l@task.org.za
-
Ledende efterforsker:
- Louis Botha
-
Underforsker:
- Alista Easton
-
-
-
-
-
Daegu, Sydkorea, 41404
- Rekruttering
- Kyungpook National University Chilgok Hospital
-
Ledende efterforsker:
- Soo Jung Lee
-
Kontakt:
- Soon Im Lee
- Telefonnummer: +82 53 200 3177
- E-mail: silee@knuh-ext.kr
-
Underforsker:
- In Hee Lee
-
Seoul, Sydkorea, 03080
- Rekruttering
- Seoul National University Hospital
-
Ledende efterforsker:
- Miso Kim
-
Kontakt:
- Jiyoo Jung
- Telefonnummer: (+82) 01046433169
- E-mail: jiyoo8843@snu.ac.kr
-
Underforsker:
- Seo Yoon Jang
-
-
-
-
Brno
-
Brno, Brno, Tjekkiet, 65653
- Rekruttering
- Masaryk Memorial Cancer Institute
-
Kontakt:
- Hana Blahynkova
- Telefonnummer: +420 543 136 233
- E-mail: hana.blahynkova@mou.cz
-
Ledende efterforsker:
- Radek Lakomy
-
Underforsker:
- Svatopluk Dobeš
-
-
Hradce Kralove
-
Sokolov, Hradce Kralove, Tjekkiet, 50009
- Rekruttering
- University Hospital Hradec Kralove
-
Ledende efterforsker:
- Jindrich Kopecky
-
Kontakt:
- Klara Reznickova
- Telefonnummer: +420495832849
- E-mail: klara.reznickova@fnhk.cz
-
-
-
-
-
Dresden, Tyskland, 01307
- Rekruttering
- University Hospital Carl Gustav Carus Dresden
-
Kontakt:
- Daniela Ruhnau
- Telefonnummer: +49 351 458 19782
- E-mail: daniela.ruhnau@ukdd.de
-
Ledende efterforsker:
- Friedegund Meier
-
Underforsker:
- Kathlen Hantsch
-
Erfurt, Tyskland, D-99089
- Rekruttering
- Helios Klinikum Erfurt
-
Kontakt:
- Cornelia Greifzu
- Telefonnummer: +49 361 781-5035
- E-mail: cornelia.greifzu@helios-gesundheit.de
-
Kontakt:
- Johann Oellers
- Telefonnummer: +49 361 781-5141
- E-mail: johann.oellers@helios-gesundheit.de
-
Ledende efterforsker:
- Rudolf Herbst
-
Underforsker:
- Diana Schellin
-
Gera, Tyskland, 07548
- Rekruttering
- SRH Wald-Klinikum Gera GmbH
-
Ledende efterforsker:
- Sabine Sell
-
Kontakt:
- Kristin Zoeger
- Telefonnummer: +49 365 828 7758
- E-mail: kristin.zoeger@srh.de
-
Kontakt:
- Mandy Michaelis
- Telefonnummer: +49 365 828 7758
- E-mail: mandy.michaelis@srh.de
-
Underforsker:
- Anne Meinzenbach
-
Münster, Tyskland, 48157
- Rekruttering
- Fachklinik Hornheide
-
Ledende efterforsker:
- Carmen Loquai
-
Kontakt:
- Konigkamp Romina
- Telefonnummer: +49 251 32 87 505
- E-mail: romina.koenigkamp@fachklinik-hornheide.de
-
-
Baden-Wurttemberg
-
Mannheim, Baden-Wurttemberg, Tyskland, 68167
- Rekruttering
- Universitätsmedizin Mannheim
-
Ledende efterforsker:
- Jochen Utikal
-
Kontakt:
- Katharina Thuene
- Telefonnummer: +49 621 383-3993
- E-mail: katharina.thuene@dkfz-heidelberg.de
-
Tübingen, Baden-Wurttemberg, Tyskland, 72076
- Rekruttering
- Universitaetsklinikum Tuebingen (UKT)
-
Kontakt:
- Melanie Peter
- Telefonnummer: +49 7071 29 84555
- E-mail: melanie.peter@med.uni-tuebingen.de
-
Ledende efterforsker:
- Andreas Meiwes
-
-
Bavaria
-
Würzburg, Bavaria, Tyskland, 97080
- Rekruttering
- Klinik für Dermatologie, Venerologie und Allergologie
-
Kontakt:
- Jana Riederer
- Telefonnummer: +49 931-201-26762
- E-mail: riederer_j@ukw.de
-
Kontakt:
- Sandra Hupfloher
- Telefonnummer: +49 931 201 26762
- E-mail: hasseli_s@ukw.de
-
Ledende efterforsker:
- Anja Gesierich
-
-
Erlangen
-
Erlangen, Erlangen, Tyskland, 91054
- Rekruttering
- University Hospital Erlangen
-
Kontakt:
- Ruth Simanek
- Telefonnummer: +49 9131 8545861
- E-mail: ruth.simanek@uk-erlangen.de
-
Ledende efterforsker:
- Carola Berking
-
-
Free and Hanseatic City of Hamburg
-
Martinsried, Free and Hanseatic City of Hamburg, Tyskland, 20246
- Rekruttering
- Universitätsklinik Hamburg Eppendorf
-
Ledende efterforsker:
- Christoffer Gebhardt
-
Kontakt:
- Christin Seeger
- Telefonnummer: +49 15222800599
- E-mail: c.seeger@uke.de
-
-
Leipzig
-
Haus, Leipzig, Tyskland, 04103
- Rekruttering
- Universität Leipzig
-
Kontakt:
- Silke Weidauer-Zuniga
- Telefonnummer: +493419718750
- E-mail: silke.weidauer-zuniga@medizin.uni-leipzig.de
-
Kontakt:
- Christin Pavlović
- Telefonnummer: +49 341 97 18380
- E-mail: christin.pavlovic@medizin.uni-leipzig.de
-
Ledende efterforsker:
- Jan Christoph Simon
-
-
Lower Saxony
-
Buxtehude, Lower Saxony, Tyskland, 21614
- Rekruttering
- Elbe Kliniken Stade-Buxtehude
-
Ledende efterforsker:
- Peter Mohr
-
Kontakt:
- Lioba Starp
- Telefonnummer: +4941617036212
- E-mail: Lioba.starp@elebekliniken.de
-
Kontakt:
- Uta Haisch
- E-mail: uta.haisch@elbekliniken.de
-
-
North Rhine-Westphalia
-
Minden, North Rhine-Westphalia, Tyskland, 32429
- Rekruttering
- Johannes Wesling Klinikum Minden
-
Kontakt:
- Helge Wuttig
- Telefonnummer: +49-(0)571-790-54528
- E-mail: helge.wuttig@muehlenkreiskliniken.de
-
Ledende efterforsker:
- Ralf Gutzmer
-
-
RLP
-
Mainz, RLP, Tyskland, 55131
- Rekruttering
- University of Mainz Medical Center
-
Ledende efterforsker:
- Stephan Grabbe
-
Kontakt:
- Claudia Bauer
- Telefonnummer: +496131175147
- E-mail: claudia.bauer@unimedizin-mainz.de
-
Kontakt:
- Susanne Wagner
- E-mail: Susanne.Wagner2@unimedizin-mainz.de
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Tyskland, 24105
- Rekruttering
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
-
Kontakt:
- Frauke Westermann
- Telefonnummer: +49 431 500 21133
- E-mail: fwestermann@dermatology.uni-kiel.de
-
Kontakt:
- Corinna Schirmann
- Telefonnummer: +49 431 500 21136
- E-mail: cschirmann@dermatology.uni-kiel.de
-
Ledende efterforsker:
- Katharina Kähler
-
Lübeck, Schleswig-Holstein, Tyskland, 23538
- Rekruttering
- Universitätsklinikum Schleswig-Holstein - Campus Lübeck
-
Kontakt:
- Jenny Koop
- Telefonnummer: +49 451 500 41570
- E-mail: jenny.koop@uksh.de
-
Kontakt:
- Beate Gehrt
- Telefonnummer: +49 451 500 41570
- E-mail: beate.gehrt@uksh.de
-
Ledende efterforsker:
- Evelyn Gaffal
-
-
State of Berlin
-
Berlin, State of Berlin, Tyskland, 10115
- Rekruttering
- Charite Department of Dermatology, Venereology and Allergology
-
Ledende efterforsker:
- Thomas Eigentler
-
Kontakt:
- Nurcan Uzun
- Telefonnummer: +49 30 450 518 448
- E-mail: nurcan.uzun@charite.de
-
-
-
-
-
Pécs, Ungarn, 7632
- Rekruttering
- University of Pécs
-
Kontakt:
- Andrea Morvane Kiss
- Telefonnummer: +3672-536-882
- E-mail: morvane.andrea@pte.hu
-
Ledende efterforsker:
- Zsuzsanna Lengyel
-
-
Budapest
-
Budapest, Budapest, Ungarn, 1122
- Rekruttering
- National Institute of Oncology
-
Kontakt:
- Barbara Varga
- Telefonnummer: +36204553579
- E-mail: varga.barbara@oncol.hu
-
Ledende efterforsker:
- Timea Balatoni
-
-
-
-
Styria
-
Graz, Styria, Østrig, 8036
- Rekruttering
- Universitätsklinikum Graz
-
Kontakt:
- Alexandra Rodlauer-Kriegl
- Telefonnummer: +43 316385 80169
- E-mail: alexandra.rodlauer-kriegl@medunigraz.at
-
Ledende efterforsker:
- Ingrid Wolf
-
Underforsker:
- Christiane Mutz-Rabl
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
To be eligible for inclusion in this study, participants must:
- Be ≥ 18 years of age on the day of signing of informed consent.
- Have a life expectancy of at least 3 months.
- Have histologically or cytologically confirmed Stage 3 (unresectable) or Stage 4 metastatic melanoma per AJCC 8th ed. and be eligible for standard therapy with pembrolizumab.
- Have at least 1 lesion with measurable disease at Baseline by CT or MRI according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 by assessment of local site Investigator/radiologist.
- Have known BRAF V600 mutation status or consent to BRAF V600 mutation testing per local institutional standards during the screening period
- Have completed prior radiotherapy at least 2 weeks prior to study treatment administration.
- Have an ECOG Performance Status of 0 to 1.
- Have adequate organ and marrow function as defined by normal CBC, coagulation, serum chemistry and liver function tests on specimens collected within 10 days of treatment start.
- Have a negative serum pregnancy test within 72 hours prior to receiving the first dose of study medication (applies to women of childbearing potential [WOCBP]).
- Be willing to use either 2 adequate methods of contraception, 1 adequate method plus a hormonal method of contraception, or be willing to abstain from heterosexual activity throughout the study (Visit 1 to 120 days after the last dose of study therapy; applies to WOCBP who are not menopausal for > 2 years, post-hysterectomy/oophorectomy, or surgically sterilized).
- Agree to use an approved adequate contraceptive method throughout the study (Visit 1 to 120 days after the last dose of study therapy; applies to sexually active male participants with a partner who is WOCBP).
- Be willing and able to provide written, informed consent for the study.
Exclusion Criteria:
A participant is excluded from the study if any of the following criteria apply:
- Has melanoma of ocular origin.
- Is currently enrolled in or has recently participated in a study of an IMP and received an IMP within 4 weeks or 5 half-lives (whichever is shorter) of administration of EIK1001 or placebo.
- Prior to the 1St dose of EIK1001 or placebo, the prospective participant has received systemic therapy for advanced melanoma.
- Note: prior adjuvant or neoadjuvant melanoma therapies (such as anti-PD-1 or anti CTLA 4 therapies or BRAF/MEK inhibitors) are permitted if all related AEs have either returned to Baseline or stabilized, with a minimum of 6 months between the last dose of prior therapy and documented disease progression.
- Experienced a ≥ Grade 3 AE while receiving prior anti PD 1 therapy.
- Has had major surgery (< 3 weeks prior to the first dose).
- Has received a live-virus vaccination within 30 days of the first dose of study treatment.
- Has a known history of prior malignancy, unless the participant has undergone potentially curative therapy with no evidence of disease recurrence for 5 years.
- Has known active CNS metastases and/or carcinomatous meningitis. Participants with previously treated brain metastases may participate if they are clinically stable for at least 4 weeks with no evidence of new or enlarging brain metastases. There must be no need for immunosuppressive doses of glucocorticoids for at least 2 weeks prior to study treatment administration.
- There is a mean resting QTcF > 470 ms on triplicate electrocardiograms.
- There is active autoimmune disease that has required systemic treatment in the past 2 years. The following autoimmune conditions are permitted: Type 1 diabetes, hypothyroidism (on hormone replacement), or- vitiligo, psoriasis and alopecia as long as no systemic treatment is required.
- There is either chronic treatment with systemic steroids, other immunosuppressive medication, or either of these has been administered within 14 days of start of study treatment.
- Note: Participants with asthma that require intermittent use of bronchodilators, inhaled steroids, or local steroid injections are eligible. Steroid replacement for adrenal insufficiency is also permitted.
- There is a history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/ interstitial lung disease.
- There are any active infections requiring therapy.
- There is uncontrolled human immunodeficiency virus (HIV) infection. HIV-infected participants with well-controlled HIV may enroll.
- There is a positive test result for hepatitis B virus (HBV) or HCV indicating presence of virus (it is expected that all participants will have been serologically tested for hepatitis B in advance of this study, with HBsAG, anti-HBc IgG, and anti-HBs as per ASCO 2020 Provisional Clinical Opinion [PCO] on universal Serologic testing for hepatitis B at the onset of anticancer therapy; screening should also include an anti-HCV test prior to start of cancer treatment:
- There is a history or clinical evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study or interfere with the participant's participation for the full duration of the study
- Known psychiatric or substance abuse disorder that would interfere with cooperation with study requirements.
- There is a known history of regular illicit drug use and/or recent history (within the last year) of substance abuse (including alcohol).
- Participant is pregnant, breastfeeding, or planning to conceive or father children within the projected duration of the study.
- Participant is currently receiving medications known to be strong inhibitors or inducers of CYP3A4 and CYP1A2.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Arm 1
Participants in this arm will receive Placebo and Standard of Care (Pembrolizumab). |
Pembrolizumab is a PD-1 inhibitor. |
|
Eksperimentel: Arm 2
Participants in this arm will receive EIK1001 (selected dose 1) + Standard of Care (Pembrolizumab). |
Pembrolizumab is a PD-1 inhibitor. EIK1001 is a Toll-like receptor 7/8 (TLR 7/8) dual agonist. |
|
Eksperimentel: Arm 3
Participants in this arm will receive EIK1001 (selected dose 2) + Standard of Care (Pembrolizumab). |
Pembrolizumab is a PD-1 inhibitor. EIK1001 is a Toll-like receptor 7/8 (TLR 7/8) dual agonist. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Progression Free Survival (PFS)
Tidsramme: up to 5 years
|
Progression-free survival (PFS) is defined as the time from the date of randomization to documented progressive disease per RECIST 1.1 by BICR or death due to any cause, whichever occurs first. |
up to 5 years
|
|
Overall survival (OS)
Tidsramme: up to 5 years
|
Overall survival (OS) defined as the time from randomization to death due to any cause. |
up to 5 years
|
|
Objective Response (OR) (Dose Optimization Only)
Tidsramme: up to 5 years
|
Objective Response (OR; defined as participants who demonstrate confirmed complete response [CR] or partial response [PR] by Response Evaluation Criteria in Solid Tumors [RECIST] version 1.1 as assessed by the Investigator) (Dose Optimization Only). |
up to 5 years
|
|
Adverse Events (AEs) (Dose Optimization Only)
Tidsramme: up to 2.5 years
|
Adverse events (AEs), and discontinuation of study treatment due to an AE (Dose Optimization Only). An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study treatment, whether or not considered related to the study treatment. |
up to 2.5 years
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Adverse Events (AEs) and Discontinuation of study treatment due to any AE.
Tidsramme: up to 2.5 years
|
Adverse events (AEs), and discontinuation of study treatment due to any AE. An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study treatment, whether or not considered related to the study treatment. |
up to 2.5 years
|
|
Objective Response (OR)
Tidsramme: up to 5 years
|
Objective response (OR) is defined as the participants who demonstrate confirmed response (CR) or partial response (PR) according to RECIST 1.1 by BICR. |
up to 5 years
|
|
Duration of Response (DOR).
Tidsramme: up to 5 years
|
Duration of Response (DOR) is defined as the time from the first documented evidence of complete response (CR) or partial response (PR) until disease progression or death due to any cause, whichever occurs first according to RECIST 1.1 by BICR. |
up to 5 years
|
|
Progression Free Survival (PFS)
Tidsramme: up to 5 years
|
Progression Free Survival (PFS) according to RECIST 1.1 by Investigator. |
up to 5 years
|
|
Objective Response (OR)
Tidsramme: up to 5 years
|
Objective Response (OR) according to RECIST 1.1 by Investigator. |
up to 5 years
|
|
Duration of Response (DOR)
Tidsramme: up to 5 years
|
Duration of Response (DOR) according to RECIST 1.1 by Investigator |
up to 5 years
|
|
Duration of Response (DOR) (Dose Optimization Only).
Tidsramme: up to 5 years
|
Duration of Response (DOR) per RECIST 1.1 by Investigator (Dose Optimization Only). |
up to 5 years
|
|
Progression-free survival (PFS) per RECIST 1.1 by Investigator (Dose Optimization Only).
Tidsramme: up to 5 years
|
Progression-free survival (PFS) per RECIST 1.1 by Investigator (Dose Optimization Only). |
up to 5 years
|
|
Overall survival (OS) (Dose Optimization Only)
Tidsramme: up to 5 years
|
Overall survival (OS) defined as the time from randomization to death due to any cause (Dose Optimization Only). |
up to 5 years
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Studieleder: Etah Kurland, Eikon Therapeutics
- Studieleder: Muaz Sadeia, Eikon Therapeutics
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- EIK1001-006
- KEYNOTE-G04 (Anden identifikator: Merck Sharp & Dohme LLC)
- MK-3475-G04 (Anden identifikator: Merck Sharp & Dohme LLC)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .